Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This is unchanged from the number of companies inspected in the previous quarter.
Most of the companies inspected at the time were involved in the Devices and Food and Cosmetics sectors. The second most common type of company inspected worked in the Biologics sector.
There were three companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Two should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Biofusion Management and Manufacturing, LLC | Devices | 02/26/2025 | Voluntary Action Indicated (VAI) |
| H-E-B San Marcos Retail Support Center | Food and Cosmetics | 02/26/2025 | No Action Indicated (NAI) |
| Hill Country Dairies, Inc. | Food and Cosmetics | 01/27/2025 | No Action Indicated (NAI) |
| Mindways Software, Inc. | Devices | 03/05/2025 | Voluntary Action Indicated (VAI) |
| Vaughn, Silverberg and Associates, LLP | Biologics | 02/19/2025 | No Action Indicated (NAI) |
Alerts Sign-up